0001209191-16-100265.txt : 20160218 0001209191-16-100265.hdr.sgml : 20160218 20160218203653 ACCESSION NUMBER: 0001209191-16-100265 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160216 FILED AS OF DATE: 20160218 DATE AS OF CHANGE: 20160218 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OncoCyte Corp CENTRAL INDEX KEY: 0001642380 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 271041563 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 HARBOR BAY PARKWAY STREET 2: SUITE 100 CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 510-521-3390 MAIL ADDRESS: STREET 1: 1301 HARBOR BAY PARKWAY STREET 2: SUITE 100 CITY: ALAMEDA STATE: CA ZIP: 94502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Last Andrew J. CENTRAL INDEX KEY: 0001485088 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37648 FILM NUMBER: 161439874 MAIL ADDRESS: STREET 1: 3420 CENTRAL EXPRESSWAY CITY: SANTA CLARA STATE: CA ZIP: 95051 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-02-16 0 0001642380 OncoCyte Corp OCX 0001485088 Last Andrew J. 3420 CENTRAL EXPRESSWAY SANTA CLARA CA 95051 1 0 0 0 Option to Purchase Common Stock 3.06 2016-02-16 4 A 0 20000 0.00 A 2026-02-15 Common Stock 20000 20000 D Option to Purchase Common Stock 3.60 2025-12-14 Common Stock 10000 10000 D Will become exercisable in four equal installments at the end of each calendar quarter based upon continued service on the board of directors from the date of grant. 2,500 options became exercisable on December 31, 2015, and the remaining 7,500 options will become exercisable in three equal quarterly installments based upon continued service on the board of directors. /s/Andrew J. Last 2016-02-18